Results 101 to 110 of about 51,995 (213)

Risk Assessment for Complex Systems Based on Fuzzy Cognitive Maps: A Case of the Biopharmaceutical Industry

Complexity
Analyzing the supply chain (SC) of biopharmaceutical drugs can be challenging due to their complexity, the existence of a wide variety of risks, and the dynamics of the system.
Hadi Abbasian, Reza Yousefi-Zenouz, Abdollah Amirkhani, Masoud Shirzadeh, Akbar Abdollahiasl, Shekoufeh Nikfar, Mohammadreza Siahi-Shadabad, Abbas Kebriaeezadeh   +7 more
doaj   +1 more source

Health economic evaluation in Japan: a case study of one aspect of health technology assessment. [PDF]

There is a burgeoning literature in health economic evaluation, with this form of analysis becoming increasingly influential at the health policy making level in a number of countries.
Oliver, Adam
core   +1 more source

Cost-effectiveness of Kang Ai injection plus chemotherapy vs. Shenqi Fuzheng injection plus chemotherapy in the first-line treatment of advanced non-small cell lung cancer

Frontiers in Medicine
ObjectiveThis study aimed to evaluate the cost-effectiveness of two Chinese patent medicines, including Kang Ai injection and Shenqi Fuzheng injection with each combined with platinum-based chemotherapy as the first-line treatment for patients with ...
Junjie Zhu, Junjie Zhu, Lei Tian, Lei Tian   +3 more
doaj   +1 more source

Analysis of the knowledge and skills of physiotherapists and physiotherapy students regarding pulmonary rehabilitation in post-COVID-19 patients

BMC Medical Education
Background Pulmonary rehabilitation plays a crucial role in the recovery of patients after COVID-19. Because training standards and clinical exposure differ internationally, the present findings should be interpreted within the Polish educational and ...
Dorota Kopciuch, Krzysztof Ciosek, Kinga Adamska, Natalia Chojara, Anna Paczkowska, Tomasz Zaprutko, Piotr Ratajczak, Elżbieta Nowakowska, Krzysztof Kus   +8 more
doaj   +1 more source

Weighting must wait: incorporating equity concerns into cost effectiveness analysis may take longer than expected [PDF]

, 2009
Current practice in economic evaluation is to assign equal social value to a unit of health improvement (“a QALY is a QALY is a QALY”). Alternative views of equity are typically considered separately to efficiency.
McCabe, C., Tsuchiya, A., Wailoo, A.
core  

Anaesthesia pharmacoeconomics [PDF]

Canadian Journal of Anaesthesia, 1993
openaire   +2 more sources

Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis

BMC Cancer
Objectives To compare the efficacy, safety and effects on quality of life of different ALK-inhibitors for global and Asian patients with advanced ALK-positive non-small-cell lung cancer (NSCLC).
Mingye Zhao, Taihang Shao, Hanqiao Shao, Caicun Zhou, Wenxi Tang   +4 more
doaj   +1 more source

Calculating the Expected Value of Sample Information using Efficient Nested Monte Carlo: A Tutorial [PDF]

, 2018
Objective: The Expected Value of Sample Information (EVSI) quantifies the economic benefit of reducing uncertainty in a health economic model by collecting additional information.
Baio, Gianluca, Heath, Anna
core   +1 more source

Efficacy and safety of proprotein convertase subtilisin/kexin type 9 inhibitors for adults with familial hypercholesterolemia: A network meta-analysis

International Journal of Cardiology. Cardiovascular Risk and Prevention
Purpose: The comparative efficacy and safety profiles of PCSK9 inhibitors in familial hypercholesterolemia (FH), including genotype-dependent treatment responses, remain unclear.
Weiwei Ding, Lingyao Sun, Yun Shi, Lei Tian   +3 more
doaj   +1 more source

Use of Discrete Choice Experiments in health economics: An update of the literature [PDF]

The vast majority of stated preference research in health economics has been conducted in the random utility model paradigm using discrete choice experiments (DCEs).
Denzil G. Fiebig, Rochelle Guttmann, Ryan Castle   +2 more
core